Efficacy of olanzapine and risperidone for treatment-refractory schizophrenia among long-stay state hospital patients

Psychiatric Services

Volumn 53, Issue 6, 2002, Pages 755-757

  Dinakar, Hassan S ^a   Sobel, Robert N ^a   Bopp, James H ^a   Daniels, Anita ^a   Mauro, Sondra ^a  

^a Rockland Psychiatric Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE; RISPERIDONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; PSYCHOPHARMACOTHERAPY; RATING SCALE; SCHIZOPHRENIA; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; COHORT STUDIES; FEMALE; HOSPITALS, PSYCHIATRIC; HOSPITALS, STATE; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; NEW YORK; PATIENT DISCHARGE; PIRENZEPINE; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0036260498     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.53.6.755     Document Type: Article

References (9)

1. Treatment-resistant schizophrenic patients respond to clozapine after olanzapine nonresponse
2. Clozapine for treatment-resistant schizophrenia
3. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome
4. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia
5. Clinical implications of clozapine discontinuation: Report of an NIMH workshop
6. Risperidone versus clozapine in treatmentresistant chronic schizophrenia: A randomized double-blind study: The Risperidone Study Group
7. Olanzapine in treatment-refractory schizophrenia: Results of an open-label study
8. Expert consensus guideline series: Treatment of schizophrenia